on 27 Feb 2024
Last Applicant/ Owned by
138 HAVERHILL STREET, SUITE 102
ANDOVER
MA
01810
Serial Number
90799299 filed on 28th Jun 2021
Registration Number
7316741 registered on 27th Feb 2024
Correspondent Address
Michael R Rizzo
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
medical and scientific research, namely, conducting clinical trials; pharmaceutical drug development services; pharmaceutical testing services business consulting services; marketing consulting services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies Read More
medical and scientific research, namely, conducting clinical trials; pharmaceutical drug development services; pharmaceutical testing services
01st Jun 2021
01st Jun 2021
business consulting services; marketing consulting services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; compilation and analysis of biostatistics for business or commercial purposes; business development services; advertising consulting services; public relations
01st Jun 2021
01st Jun 2021
No 90799299
No Service Mark
No 629.429.33
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
08th Aug 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
27th Feb 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
27th Feb 2024 | REGISTERED-PRINCIPAL REGISTER |
25th Jan 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
24th Jan 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
19th Dec 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
18th Dec 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
18th Dec 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
19th Sep 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
19th Sep 2023 | NON-FINAL ACTION E-MAILED |